These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 894046)

  • 1. A mycoplasma mutant resistant to lysis by C: variations in membrane composition and altered response to the terminal C complex.
    Dahl JS; Hellewell SB; Levine RP
    J Immunol; 1977 Oct; 119(4):1419-26. PubMed ID: 894046
    [No Abstract]   [Full Text] [Related]  

  • 2. Replacement of the octadecenoic acid growth-requirement for Acholeplasma laidlawii A by cis-9,10-methylenehexadecanoic acid, a cyclopropane fatty acid.
    Panos C; Leon O
    J Gen Microbiol; 1974 Jan; 80(1):93-100. PubMed ID: 4820352
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement-mediated killing of Acholeplasma laidlawii by antibodies to various membrane components.
    Dörner I; Brunner H; Schiefer HG; Wellensiek HJ
    Infect Immun; 1976 Jun; 13(6):1663-70. PubMed ID: 61175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid composition of Acholeplasma laidlawii cells].
    Abaeva TP; Dobrynina OV; Tarshis MA
    Mikrobiologiia; 1976; 45():554-6. PubMed ID: 1004257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysis of Acholeplasma laidlawii by antibodies and complement.
    Brunner H; Dörner I; Schiefer HG; Krauss H; Wellensiek HJ
    Infect Immun; 1976 Jun; 13(6):1671-7. PubMed ID: 971945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid distribution in Acholeplasma laidlawii membrane. A study using the lactoperoxidase-mediated iodination.
    Gross Z; Rottem S
    Biochim Biophys Acta; 1979 Aug; 555(3):547-52. PubMed ID: 486468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol uptake capacity of Acholeplasma laidlawii is affected by the composition and content of membrane glycolipids.
    Efrati H; Wax Y; Rottem S
    Arch Biochem Biophys; 1986 Jul; 248(1):282-8. PubMed ID: 3729418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical composition and serology of Mycoplasma pneumoniae lipids.
    Pollack JD; Somerson NL; Senterfit LB
    J Infect Dis; 1973 Mar; 127():Suppl:S32-5. PubMed ID: 4689627
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of lipid fatty acyl composition and membrane fluidity in the resistance of Acholeplasma laidlawii to complement-mediated killing.
    Dahl JS; Dahl CE; Levine RP
    J Immunol; 1979 Jul; 123(1):104-8. PubMed ID: 448140
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of the membrane composition of Mycoplasma mycoides subsp. capri by the growth medium.
    Archer DB
    J Gen Microbiol; 1975 Jun; 88(2):329-38. PubMed ID: 1097587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoreaction of lipids--a step in the study of the membrane structure].
    Inoue K; Nojima S
    Tanpakushitsu Kakusan Koso; 1971 Aug; 16(8):565-79. PubMed ID: 4327904
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunogenicity of Mycoplasma pneumoniae glycolipids: a novel approach to the production of antisera to membrane lipids.
    Razin S; Prescott B; Chanock RM
    Proc Natl Acad Sci U S A; 1970 Oct; 67(2):590-7. PubMed ID: 4943173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-lipid interactions in biological and model membrane systems. Deuterium NMR of Acholeplasma laidlawii B, Escherichia coli, and cytochrome oxidase systems containing specifically deuterated lipids.
    Kang SY; Kinsey RA; Rajan S; Gutowsky HS; Gabridge MG; Oldfield E
    J Biol Chem; 1981 Feb; 256(3):1155-9. PubMed ID: 6256386
    [No Abstract]   [Full Text] [Related]  

  • 14. Lysis and death of Mycoplasma pneumoniae by antibody and complement.
    Brunner H; Razin S; Kalica AR; Chanock RM
    J Immunol; 1971 Apr; 106(4):907-16. PubMed ID: 4928746
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies to Acholeplasma laidlawii membrane lipids in normal guinea pig serum.
    Dörner I; Brunner H; Schiefer HG; Loos M; Wellensiek HJ
    Infect Immun; 1977 Oct; 18(1):1-7. PubMed ID: 908614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential scanning calorimetric study of the interaction of cholesterol with the major lipids of the Acholeplasma laidlawii B membrane.
    McMullen TP; Wong BC; Tham EL; Lewis RN; McElhaney RN
    Biochemistry; 1996 Dec; 35(51):16789-98. PubMed ID: 8988017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of independent variations in fatty acid structure and chain length on lipid polar headgroup composition in Acholeplasma laidlawii B membranes: regulation of lamellar/nonlamellar phase propensity.
    Yue AW; Wong BC; Rieder J; Lewis RN; Mannock DA; McElhaney RN
    Biochemistry; 2003 Feb; 42(5):1309-17. PubMed ID: 12564934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Accumulation of cholesterol in Acholeplasma laidlawii membranes in the steady-state phase of culture growth].
    Kapitanov AB; Ladygina VG; Mukhankin AI; Ivanova VF; Klebanov GI
    Biokhimiia; 1983 Nov; 48(11):1921-6. PubMed ID: 6661465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK; Johnson RC; Dalmasso AP
    J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.